Mitotech
Pre-clinicalMitotech is a biotechnology company with a portfolio of novel mitochondria-targeted small molecules
Founded
2012
Focus
Small Molecules
About
Mitotech is a biotechnology company with a portfolio of novel mitochondria-targeted small molecules
Funding History
2Total raised: $75M
Series B$50MUndisclosedNov 15, 2019
Series A$25MUndisclosedMay 15, 2016
Company Info
TypePrivate
Founded2012
LocationLondon, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile